Yanick Fanton

Yanick Fanton

Company: Beta-Cell NV

Job title: Lab Director

Seminars:

BREAKOUT DISCUSSION GROUPS 12:00 pm

• What are the possible therapeutic approaches of gene therapies for diabetes and how do they compare with cell replacement approaches? • How can we optimize cell therapy efficacy through utilizing gene engineering mechanisms? • How can gene engineering be utilized to reduce alloimmune and autoimmune-mediated rejection of cells? • What is the importance and…Read more

day: Day Three

PANEL DISCUSSION: Advantages or Limitations of Cell and Gene Therapies 11:00 am

• Pros and cons of cells vs gene approaches • Gene transfer methods: non-viral vs. viral • Genetically engineering cells for enhanced efficacy • Cost vs. value of each methodology • What does the manufacturing strategy for these approaches look like?Read more

day: Day Three

CASE STUDY: Exploring Gene Editing as a Means to Protect Transplanted Cells from a Patients’ Immune System 9:20 am

• Learning how the advent of novel gene editing tools provides unique opportunities to disassemble MHC components in stem cell lines used to produce pancreatic-lineage cells to prevent presentation of allo-antigens and autoantigens by the stem cell-derived beta cells and recognition by memory autoimmune cells in T1D patients • To what extent can eliminating MHC…Read more

day: Day Three

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.